Emergent Biosolutions CEO on the vaccine factory mix-up

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • NY proposes SALT workaround for hedge funds, other partnerships
  • SPACs are here to stay, says former NYSE CFO Amy Butte
  • TechCheck premieres Monday at 11 am ET on CNBC
  • CNBC Television published this video item, entitled “Emergent Biosolutions CEO on the vaccine factory mix-up” – below is their description.

    Emergent Biosolutions CEO Robert Kramer joins CNBC’s Meg Tirrell to discuss the mix up between the ingredients of the AstraZeneca vaccine and the J&J vaccine. However, the mistake was caught early on and the vials were not been released to the public. He joins ‘Closing Bell’ to discuss.

    CNBC Television YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: AstraZeneca

    AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

    3 Recent Items: AstraZeneca

  • Coronavirus pandemic: France opens up vaccine eligibility to over 55s
  • COVID-19: Have AstraZeneca been unfairly criticised?
  • Coronavirus: Victorians to wait two weeks for AstraZeneca vaccine | 9 News Australia
  • Leave a Comment